[-] Show simple item record

dc.contributor.authorMalaty, Waileng
dc.contributor.authorStigleman, Sueeng
dc.date.issued2008-08eng
dc.description.abstractRoutine monitoring of antiepileptic drug levels does not alter seizure or side effect rates. (Strength of Recommendation [SOR]: B, based on a single randomized controlled trial [RCT] with less than 80 percent follow-up). Antiepileptic drug level monitoring may be clinically useful in special populations, including patients with suspected drug toxicity or noncompliance, pregnant patients, and patients with renal failure. Monitoring dosage increases of drugs with nonlinear kinetics, such as phenytoin (Dilantin), may be useful. (SOR: C, based on expert opinion). Therapeutic drug level monitoring of newer antiepileptic drugs has not been shown to be clinically useful. (SOR: C, based on expert opinion).eng
dc.identifier.citationAmerican Family Physician, 78(3) 2008: 385+eng
dc.identifier.urihttp://hdl.handle.net/10355/3770eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofClinical Inquiries, 2008 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectepilepsyeng
dc.subjectseizureeng
dc.subjectdrug level monitoringeng
dc.subject.lcshAnticonvulsantseng
dc.subject.lcshDrug monitoringeng
dc.subject.lcshEpilepsy -- Treatmenteng
dc.titleAntiepileptic Drug Level Monitoringeng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record